These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 958273)

  • 1. Letter: Racial representation in pharmaceutical advertising.
    Covington EJ; Roland CG
    N Engl J Med; 1976 Sep; 295(14):789. PubMed ID: 958273
    [No Abstract]   [Full Text] [Related]  

  • 2. More on sex and racial bias in pharmaceutical advertisements.
    Tietze KJ; Smith MC
    N Engl J Med; 1990 May; 322(21):1534. PubMed ID: 2336085
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Improved pharmaceutical advertisements.
    Stetler CJ
    N Engl J Med; 1974 Aug; 291(8):422-3. PubMed ID: 4847364
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmaceutical advertising. Information or influence?
    Dixon T
    Can Fam Physician; 1993 Jun; 39():1298-300, 1302-4. PubMed ID: 8324397
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased direct-to-consumer advertising driving pharmaceutical costs, trends.
    Fine A
    Exec Solut Healthc Manag; 1999 Jan; 2(1):2-3. PubMed ID: 10345986
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of direct-to-consumer advertising on healthcare providers and consumers.
    Mahon SM
    Clin J Oncol Nurs; 2006 Jun; 10(3):417-20. PubMed ID: 16789585
    [No Abstract]   [Full Text] [Related]  

  • 7. Europe on the brink of direct-to-consumer drug advertising.
    Lancet; 2002 May; 359(9319):1709. PubMed ID: 12049853
    [No Abstract]   [Full Text] [Related]  

  • 8. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 9. "New products parade".
    N Engl J Med; 1969 May; 280(19):1074-5. PubMed ID: 5778417
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessments of pharmaceutical advertisements: a critical analysis of the criticism.
    Beales JH; MacLeod WC
    Food Drug Law J; 1995; 50(3):415-49. PubMed ID: 10343010
    [No Abstract]   [Full Text] [Related]  

  • 11. The ethical implications of direct-to-consumer pharmaceutical advertising.
    Farrell JM
    Philos Public Policy Q; 2003; 23(3):20-3. PubMed ID: 15282933
    [No Abstract]   [Full Text] [Related]  

  • 12. DTC drug ads in the spotlight.
    Guglielmo WJ
    Med Econ; 2006 Sep; 83(18):20. PubMed ID: 17037630
    [No Abstract]   [Full Text] [Related]  

  • 13. Faces and races in drug ads.
    Morris RJ
    N Engl J Med; 1976 Nov; 295(22):1264. PubMed ID: 980051
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct-to-consumer advertising.
    Haddy FJ
    Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(3):38-9. PubMed ID: 20690556
    [No Abstract]   [Full Text] [Related]  

  • 15. Code of fair practices in the promotion of drug products.
    Md State Med J; 1967 Dec; 16(12):139-40. PubMed ID: 6079133
    [No Abstract]   [Full Text] [Related]  

  • 16. Sources of drug information.
    Albert BL
    N Engl J Med; 1969 Jan; 280(5):274. PubMed ID: 5762172
    [No Abstract]   [Full Text] [Related]  

  • 17. Who reviews the ads?
    Relman AS
    N Engl J Med; 1979 Nov; 301(18):999. PubMed ID: 492232
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA wins spoof award for its "collusion" with the drug industry.
    Lenzer J
    BMJ; 2005 Mar; 330(7491):555. PubMed ID: 15760976
    [No Abstract]   [Full Text] [Related]  

  • 19. The extent of advertising of pharmaceutical products.
    Stimson GV
    J R Coll Gen Pract; 1976; 26 Suppl 1(Suppl 1):69-76. PubMed ID: 1011223
    [No Abstract]   [Full Text] [Related]  

  • 20. O-t-c advertising--benefit or detriment?
    Thain GJ; Bickart DO
    J Am Pharm Assoc; 1972 Oct; 12(10):508-10 passim. PubMed ID: 5069352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.